Efficacy of deep brain stimulation for the treatment of anorexia nervosa: a systematic review and network meta-analysis of patient-level data

Abstract

OBJECTIVE Deep brain stimulation (DBS) has been approved as a therapy for movement disorders and obsessive-compulsive disorder. Recently, DBS has been studied in patients with anorexia nervosa (AN), which is a debilitating and life-threatening psychiatric disorder. Several stimulation locations have been tested without a clear indication of the best region. In this systematic review and network meta-analysis, the authors used patient-level data to identify stimulation targets with the greatest evidence for efficacy in increasing body mass index (BMI). METHODS A systematic search was performed on or before August 4, 2022, using PubMed/MEDLINE, Ovid, and Scopus. Articles were included if patient-level data were presented, patients were diagnosed with AN and treated with DBS, and 6 months or more of postoperative follow-up data were reported. Quality and risk of bias were assessed with the NIH assessment tools. Patient data were collected and stratified by stimulation location. A network meta-analysis was performed. This review was written in accordance with PRISMA guidelines for systematic reviews. RESULTS Eleven studies consisting of 36 patients were included. The mean age and BMI at the time of surgery were 38.07 (SD 11.64) years and 12.58 (SD 1.4) kg/m2, respectively. After 6 months of DBS, a significant difference in percentage change in BMI was found between the nucleus accumbens and subcallosal cingulate cortex (SCC) (SMD 0.78; 95% CI 0.10, 1.45) and between the SCC and ventral anterior limb of the internal capsule (SMD −1.51; 95% CI −2.39, −0.62). Similarly, at 9–12 months, a significant difference in percentage change in BMI was found between the SCC and ventral anterior limb of the internal capsule (SMD −1.18; 95% CI −2.21, −0.15). With hierarchical ranking, this study identified SCC as the most supported stimulation location for BMI change at 6 and 9–12 months (P-scores 0.9449 and 0.9771, respectively). CONCLUSIONS Several DBS targets have been tested for AN, and this study identified the SCC as the most supported region for BMI change. However, further studies with blinded on/off periods are necessary to confirm this finding.

Anorexia nervosa through the lens of a severe and enduring experience: ‘lost in a big world’

“…Anxiolytics are underexplored and psychedelics e.g. psilocybin as well as other brain based therapies [ 31 ] are experimental in SE-AN, with preliminary evidence [ 6 ]. The efficacy and safety of repeated delivery of the same treatments over decades is not established and given that less than 63% of people with AN have achieved recovery after 22 years [ 4 ], ongoing care options are needed.…”